Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous disease.

Journal of human immunity·2026
Same author

Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia models.

Cell reports. Medicine·2026
Same author

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia.

Blood·2026
Same author

Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.

Obstetrical & gynecological survey·2025
Same author

Allo-defensive, multiplex base-edited, anti-CD38 CAR T cells for 'off-the-shelf' immunotherapy.

Haematologica·2025

Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.8K

Hybrid lentiviral vectors.

Waseem Qasim1, Conrad A Vink, Adrian J Thrasher

  • 1Molecular Immunology Unit, Institute of Child Health, University College London, London, UK. w.qasim@ich.ucl.ac.uk

Molecular Therapy : the Journal of the American Society of Gene Therapy
|April 22, 2010
PubMed
Summary

Hybrid lentiviral vectors offer a promising gene therapy solution by combining HIV entry with DNA modification systems. These vectors aim for durable genetic modification with improved safety profiles, overcoming limitations of traditional methods.

More Related Videos

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.8K
Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.1K

Related Experiment Videos

Last Updated: Jan 12, 2026

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.8K
Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.8K
Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.1K

Area of Science:

  • Gene Therapy
  • Molecular Biology
  • Virology

Background:

  • Lentiviral vectors are valuable for gene therapy due to their efficient cell entry and gene delivery.
  • Integration-competent gene delivery systems raise concerns about insertional mutagenesis.
  • Integration-deficient lentiviral vectors provide durable transcription in non-mitotic cells but are lost in dividing cells.

Purpose of the Study:

  • To review advancements in hybrid lentiviral vector systems.
  • To explore the potential applications of these novel vectors in gene therapy.
  • To address the limitations of current gene delivery methods.

Main Methods:

  • Development of hybrid lentiviral vectors by incorporating DNA modification systems (e.g., nuclease-enhanced homologous recombination, artificial transposons) into the viral genome.
  • Harnessing the cell entry capabilities of human immunodeficiency virus (HIV).
  • Utilizing viral genomes to facilitate the delivery of gene modification tools into challenging-to-transfect cells.

Main Results:

  • Hybrid lentiviral vectors demonstrate potential for durable genetic modification.
  • These systems offer more favorable integration profiles compared to traditional lentiviral vectors.
  • The approach allows for the "hitch-hiking" of gene modification systems into target cells.

Conclusions:

  • Hybrid lentiviral vectors represent a significant advancement in gene therapy.
  • They offer a strategy to achieve long-lasting genetic modification with reduced risks.
  • Further research into their applications could revolutionize therapeutic approaches for genetic disorders.